Application
17753336 · LIGAND-2'-MODIFIED NUCLEIC ACIDS, SYNTHESIS THEREOF AND INTERMEDIATE COMPOUNDS THEREOF
Filed 2022-02-28 · Abandoned The official file ↗ · Art unit 1691 · Examiner Jaret James Crews Hard · CPC C07H 1/00 · Dicerna Pharmaceuticals, Inc. · Dechert LLP/Dicerna
Office actions
0
first was Restriction requirement
RCEs
0
no appeal
To first action
37.4 mo
to disposition 44.9 mo
Statutes raised
·
0 actions read